| Nome del prodotto | Gliclazide |
|---|---|
| Numero CAS | 21187-98-4 |
| Formula molecolare | C15H21N3O3S |
| Peso molecolare | 323.41 g/mol |
| Aspetto | White or almost white crystalline powder |
| Analisi (HPLC) | 98.0% - 102.0% |
| Perdita per essiccazione | ≤ 0,51 TP3T |
| Residuo di combustione | ≤ 0,11 TP3T |
| Metalli pesanti | ≤ 10 ppm |
| Punto di fusione | 163°C - 169°C |
| Rotazione specifica | Not applicable (racemic mixture) |
Hai bisogno di aiuto? Contatta il nostro team

Gliclazide has been a cornerstone in type 2 diabetes management for decades, and it’s still widely prescribed today — because it works. As a second-generation sulfonylurea, it stimulates insulin release from pancreatic beta cells, helping patients lower blood glucose without the extreme peaks and troughs seen with some older agents. What sets gliclazide apart is its unique azabicyclo-octyl ring, which gives it a favorable safety profile, particularly for cardiovascular outcomes. That’s why it remains a trusted choice in many national formularies, especially in Europe and Asia.
For manufacturers and formulators, gliclazide offers a reliable, well-documented API with predictable pharmacokinetics and a proven track record. We supply gliclazide as a high-purity crystalline powder, every batch meeting strict pharmacopoeial standards and shipped with a full COA. Whether you need a 1 kg sample for R&D or a full container load for commercial production, we’ve got the flexibility and logistics to keep your supply chain moving.